In the current study on NSCLC cells, acetylshikonin treatment led to RIPK1/RIPK3/MLKL phosphorylation, which is a crucial step in triggering the necroptosis signaling pathway [53, 59]. This evidence concerns the gene RIPK3 and non-small cell lung carcinoma.